Inflammatory Pain - Pipeline Review, H1 2014

The Report Inflammatory Pain - Pipeline Review, H1 2014 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz

Logo

Albany, NY -- (SBWire) -- 11/10/2014 --Global Markets Directs, Inflammatory Pain - Pipeline Review, H1 2014, provides an overview of the Inflammatory Pains therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Inflammatory Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Inflammatory Pain and special features on late-stage and discontinued projects.

View Full Report
http://www.marketresearchreports.biz/analysis/195050

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Download Detail Report With Complete TOC
http://www.marketresearchreports.biz/sample/sample/195050

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Explore All Latest Published Reports By Global Markets Direct
http://www.marketresearchreports.biz/publisher/37

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope:

- The report provides a snapshot of the global therapeutic landscape of Inflammatory Pain

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Inflammatory Pain and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Inflammatory Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Inflammatory Pain pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

Reasons to buy:

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Inflammatory Pain

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Inflammatory Pain pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Related Reports

Insulin Pen Market, Users (Reusable & Prefilled) & Forecast - Worldwide Analysis

View Full Report
http://www.marketresearchreports.biz/analysis/217363

In 2013, more than 50 Thousand insulin users opt for an insulin pen. Out of this major percentage of population uses Reusable (Cartridge) insulin pen compared to Prefilled (Disposable) insulin pen. Insulin Pen market for 2013 is in double digit Billion US$ and it is expected to grow by 13% from 2013 to 2018. With such incredible growth, the demand for insulin pen is increasing exceptionally across the globe. Across the globe, insulin pen devices are the most widely applied method of insulin delivery after vial and syringe method.

Download Detail Report With Complete TOC
http://www.marketresearchreports.biz/sample/sample/217363

Growth in insulin pen devices market is likely to be hinged at United States, China, India and Brazil in the coming years. Japan and European markets have reached maturation period for the pen devices market. Knowing these facts, the major players in the insulin pen devices market are strategically focusing on the Asian market, in order to cater the rapidly increasing demand of insulin pen devices.

Feminax Ultra-Drug Insights,2014

View Full Report
http://www.marketresearchreports.biz/analysis/218637

DelveInsights pharmaceuticals report, Feminax Ultra - Drug Insights, 2014 provides Feminax Ultra marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015).

Download Detail Report With Complete TOC
http://www.marketresearchreports.biz/sample/sample/218637

The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

About Marketresearchreports.biz
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog at http://2014marketresearch.blogspot.com/

Media Relations Contact

Sheela AK
Business Head
Market Research Reports.biz
518-618-1030
http://www.marketresearchreports.biz/

View this press release online at: http://rwire.com/560705